Streetbeat News

Products Services

RIO

Rio Tinto (NYSE:RIO) is set to receive approval from Serbia to develop Europe's largest lithium mine, the Jadar project, by 2028. This project aims to produce significant amounts of lithium carbonate, boric acid, and sodium sulfate, crucial for the EV industry and other industrial applications. Despite past environmental concerns and opposition, new guarantees from Rio Tinto and the EU have addressed these issues, leading to the project's revival.

Portfolio Pulse from Stjepan Kalinic

June 17, 2024 | 1:12 pm

INTC

TSM

TSMC has received orders for 3nm chips from Intel for its upcoming notebook processor series, with wafer production already underway.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 1:12 pm

NVDA

NVIDIA has contributed the largest ever indoor synthetic dataset to the AI City Challenge at the CVPR conference, aiding the development of AI models for smart cities and industrial automation. The dataset, created using NVIDIA Omniverse, includes 212 hours of 1080p video and features nearly 1,000 cameras and 2,500 digital human characters. This initiative aims to enhance operational efficiency in physical settings such as retail and warehouse environments.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 1:10 pm

NVDA

NVIDIA won the Autonomous Grand Challenge at the CVPR conference with its Hydra-MDP model for end-to-end driving. The company also showcased its advancements in accelerated computing and generative AI for autonomous vehicle development, including the NVIDIA Omniverse Cloud Sensor RTX microservices.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 1:10 pm

LI

NIO

TSLA

XPEV

Nio Inc. (NYSE:NIO) reported a widened loss for Q1 2023, with revenue down 7.2% year-on-year. The company is diversifying its brand to target middle and lower market segments with new brands Onvo and Firefly. Despite heavy investments in R&D and infrastructure, Nio faces stiff competition and regulatory challenges in foreign markets.

Portfolio Pulse from The Bamboo Works

June 17, 2024 | 1:10 pm

SLS

SELLAS Life Sciences announced that the Independent Data Monitoring Committee (IDMC) has recommended the continuation of the Phase 3 REGAL clinical trial of Galinpepimut-S in Acute Myeloid Leukemia without any modifications. No safety or futility concerns were raised, and an interim analysis is anticipated by Q4 2024.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 1:07 pm

GSK

ITOS

iTeos Therapeutics and GSK have initiated the GALAXIES Lung-301 Phase 3 study to assess the efficacy of belrestotug and dostarlimab in treating previously untreated, unresectable, locally advanced or metastatic PD-L1 selected non-small cell lung cancer. The primary endpoints are progression-free survival and overall survival.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 1:07 pm

BHP

CMP

DOW

Wall Street's most accurate analysts have spotlighted three high-dividend-yielding materials stocks: Dow Inc. (DOW), Compass Minerals International, Inc. (CMP), and BHP Group Limited (BHP). Analysts have provided various ratings and price targets for these stocks, and recent news includes supply agreements, executive appointments, and collaborations on new technology.

Portfolio Pulse from Avi Kapoor

June 17, 2024 | 1:06 pm

PHG

Philips has received FDA 510(k) clearance for its Zenition 90 Motorized Mobile C-Arm, designed to enhance image quality and support complex vascular and other clinical procedures. The new system aims to improve clinician productivity and patient outcomes.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 1:05 pm

KDLY

KindlyMD has expanded its insurance coverage by partnering with Blue Cross Blue Shield, now providing nearly 80% statewide comprehensive insurance coverage.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 1:05 pm